Introducing our innovative Safe’n’Sound® in 2.25 mL size


Safe'n'Sound 2.25ml: Robust and ergonomic design for user safety, suitable for biologic and high-value drugs

“Introducing our innovative Safe’n’Sound® in 2.25 mL size”: premium add-on and highly customizable passive safety devices adapted to your complex injectable formulations.

The platform is suitable for low fill volumes and high viscosity formulations. It is robust against shocks and vibrations, and can run with manual and fully automated assembly lines.”

The growing prevalence of chronic diseases, along with the evolution of patients’ lifestyles, is driving new ways of administrating parenteral drugs. Novel treatments have become available, with the majority arising from biological molecules. Biologic drugs are predominantly administered via injectable devices, using prefilled syringes as a base. Safe’n’Sound® is a passive, one-handed safety device and is intended to be used by non-experienced users for self-administration as well as by healthcare professionals.

The Safe’n’Sound® needle safety device platform is now available to accommodate 2.25 mL fill volume prefilled syringes. This new 2.25 mL size is specifically relevant to administer complex, high-value drugs such as monoclonal antibodies or other biological therapies. It offers a reliable and intuitive design for user safety, and is compatible with any type of ISO standard 2.25 mL prefilled glass syringe, including various flange types.

Nemera understands the importance of device optimization to increase patient safety during self-administration of medication. Self-administration at home therefore translates into a need for safer, easy-to-use and ergonomic devices. Having patients (or caregivers who are not healthcare professionals) inject a drug brings increased risk of usage errors and needle-stick injuries. Protecting users from sharps injuries, whilst optimizing the injection experience, has become compulsory.

In light of this, the priority is to understand the patient journey in order to provide better outcomes. At the earliest stages of establishing the requirement and user needs for a delivery platform, Nemera works with customers to fully understand the patient journey by using a technique called applied ethnography. This method relies on a combination of interviews and in-context observations of practices, processes and experiences within the patient’s home or natural environment.

Regulations and recommendations are evolving to improve patient and health worker safety. In this context, Nemera’s Safe’n’Sound® product range matches the need for safe and easy-to-use self-deliveries – this passive safety device for prefilled syringes provides increased safety for patients and healthcare professionals.


About Nemera

Nemera is a world leader in the design, development, and manufacturing of drug delivery devices for the pharmaceutical, biotechnology and generics industries. Nemera offers a comprehensive portfolio of products and services across ophthalmology, nasal, inhalation, dermal, transdermal and parenteral delivery. Nemera’s vision is to be the most patient-centric drug delivery device company. Nemera always puts patients first, providing high-quality solutions that have a demonstrable impact on patients’ health

Nemera’s newly branded Insight Innovation Center, with offices in North America and Europe, provides consultative services to support your overall device strategy. Providing user research, Human Factors, User Experience design, and Design for manufacturing, the Insight Innovation Center can help customers navigate their device strategy for both novel and platform solutions. Users are at the center of everything that we do in our effort to always put patients first.

Latest News